A bioavailability study in the proposed patient population--with much more needed now.
Freedman
Michael D
MD
D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000990:Antithrombin III / Q000378:metabolism*; D001682:Biological Availability; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D016903:Drug Monitoring / Q000379:methods; D017984:Enoxaparin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D007279:Injections, Subcutaneous; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D000990:Antithrombin III